[PDF][PDF] Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Journal of clinical oncology, 2008•researchgate.net
Purpose Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor
(ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2)
expression. In this study, we compared response to neoadjuvant chemotherapy and survival
between patients with TNBC and non-TNBC.
(ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2)
expression. In this study, we compared response to neoadjuvant chemotherapy and survival
between patients with TNBC and non-TNBC.
Purpose
Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherapy and survival between patients with TNBC and non-TNBC.
researchgate.net